Charles Schwab’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,225
| Closed | -$96.6K | – | 3541 |
|
|
2025
Q1 | $96.6K | Sell |
11,225
-1,280
| -10% | -$19.8K | ﹤0.01% | 3345 |
|
|
2024
Q4 | $447K | Hold |
12,505
| – | – | ﹤0.01% | 3172 |
|
|
2024
Q3 | $591K | Hold |
12,505
| – | – | ﹤0.01% | 3105 |
|
|
2024
Q2 | $628K | Buy |
12,505
+670
| +6% | +$48.4K | ﹤0.01% | 3098 |
|
|
2024
Q1 | $1.33M | Sell |
11,835
-488
| -4% | -$48.5K | ﹤0.01% | 2710 |
|
|
2023
Q4 | $715K | Buy |
12,323
+547
| +5% | +$22K | ﹤0.01% | 2948 |
|
|
2023
Q3 | $374K | Sell |
11,776
-21,052
| -64% | -$1M | ﹤0.01% | 3154 |
|
|
2023
Q2 | $2.7M | Buy |
32,828
+3,641
| +12% | +$533K | ﹤0.01% | 2459 |
|
|
2023
Q1 | $3M | Buy |
29,187
+2,346
| +9% | +$329K | ﹤0.01% | 2413 |
|
|
2022
Q4 | $3.93M | Buy |
26,841
+1,095
| +4% | +$185K | ﹤0.01% | 2338 |
|
|
2022
Q3 | $4.35M | Sell |
25,746
-501
| -2% | -$81.4K | ﹤0.01% | 2288 |
|
|
2022
Q2 | $3.03M | Buy |
26,247
+7,661
| +41% | +$721K | ﹤0.01% | 2411 |
|
|
2022
Q1 | $1.85M | Sell |
18,586
-934
| -5% | -$109K | ﹤0.01% | 2672 |
|
|
2021
Q4 | $3.04M | Buy |
19,520
+228
| +1% | +$44.4K | ﹤0.01% | 2566 |
|
|
2021
Q3 | $4.55M | Buy |
19,292
+2,793
| +17% | +$816K | ﹤0.01% | 2423 |
|
|
2021
Q2 | $5.6M | Buy |
16,499
+1,692
| +11% | +$641K | ﹤0.01% | 2297 |
|
|
2021
Q1 | $5.99M | Buy |
14,807
+477
| +3% | +$231K | ﹤0.01% | 2206 |
|
|
2020
Q4 | $9.53M | Buy |
14,330
+191
| +1% | +$106K | ﹤0.01% | 1895 |
|
|
2020
Q3 | $6.58M | Buy |
14,139
+9,391
| +198% | +$4.75M | ﹤0.01% | 1938 |
|
|
2020
Q2 | $2.78M | Buy |
4,748
+1,304
| +38% | +$445K | ﹤0.01% | 2300 |
|
|
2020
Q1 | $502K | Buy |
3,444
+42
| +1% | +$7.34K | ﹤0.01% | 2713 |
|
|
2019
Q4 | $488K | Hold |
3,402
| – | – | ﹤0.01% | 2823 |
|
|
2019
Q3 | $135K | Hold |
3,402
| – | – | ﹤0.01% | 3081 |
|
|
2019
Q2 | $345K | Buy |
3,402
+2,008
| +144% | +$237K | ﹤0.01% | 2971 |
|
|
2019
Q1 | $184K | Buy |
1,394
+414
| +42% | +$52.1K | ﹤0.01% | 3037 |
|
|
2018
Q4 | $100K | Sell |
980
-144
| -13% | -$22.8K | ﹤0.01% | 3089 |
|
|
2018
Q3 | $281K | Buy |
1,124
+144
| +15% | +$48.3K | ﹤0.01% | 3019 |
|
|
2018
Q2 | $438K | Buy |
980
+168
| +21% | +$73.7K | ﹤0.01% | 2846 |
|
|
2018
Q1 | $321K | Buy |
+812
| New | +$321K | ﹤0.01% | 2854 |
|
Other funds holding MRSN
NI
BCLSI
SSA
RSCM
SCM
